Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Dividend History CABA

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Dividend Analytics CABA

Max Ratio

5Y Dividend Growth

Consecutive Years

5Y Average Payout Ratio

Forward Annual Dividend Yield
Consecutive Years
Forward Annual Dividend – USD
Consistent Years
Dividend CAGR 3Y
Continuous Dividends
Dividend CAGR 5Y
Payout Ratio TTM
Dividend CAGR 10Y
Ex Dividend Date

Cabaletta Bio Inc

CABA
Current price
1.63 USD -0.07 USD (-4.12%)
Last closed 1.69 USD
ISIN US12674W1099
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 156 501 008 USD
Yield for 12 month -79.26 %
1Y
3Y
5Y
10Y
15Y
CABA
21.11.2021 - 28.11.2021

Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with autoimmune diseases. Its lead product candidate is resecabtagene autoleucel, a 4-1BB co-stimulatory domain-containing fully human CD19-CAR T, which is in Phase 1/2 clinical trials for the treatment of dermatomyositis, anti-synthetase syndrome, immune-mediated necrotizing myopathy, juvenile myositis, lupus nephritis, non-renal systemic lupus erythematosus, relapsing and progressive multiple sclerosis, mucocutaneous and mucosal pemphigus vulgaris (PV), systemic sclerosis, and generalized myasthenia gravis. The company also develops DSG3-CAART, a CAAR T cell therapy that is in Phase 1 clinical trial for the treatment of mucosal PV; and MuSK-CAART, an investigational cell therapy in Phase 1 trial for treating patients with anti-muscle-specific kinase (MuSK) antibody positive myasthenia gravis. It has a collaboration with the University of Pennsylvania and the Children's Hospital of Philadelphia; Nanjing IASO Biotherapeutics Co., Ltd; Oxford Biomedica; Autolus Holdings (UK) Limited; and WuXi Advanced Therapies, Inc. The company was formerly known as Tycho Therapeutics, Inc. and changed its name to Cabaletta Bio, Inc. in August 2018. Cabaletta Bio, Inc. was incorporated in 2017 and is headquartered in Philadelphia, Pennsylvania. Address: 2929 Arch Street, Philadelphia, PA, United States, 19104

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

15.67 USD

P/E Ratio

Dividend Yield

Financials CABA

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Key Figures CABA

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Current Year

Last Year

Current Quarter

Last Quarter

Current Year

Last Year

-1 426 000 USD

Current Quarter

Last Quarter

EBITDA -132 443 000 USD
Operating Margin TTM
Price to Earnings
Return On Assets TTM -41.37 %
PEG Ratio
Return On Equity TTM -73.85 %
Wall Street Target Price 15.67 USD
Revenue TTM
Book Value 2.40 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY
Dividend Yield
Gross Profit TTM
Earnings per share -2.54 USD
Diluted Eps TTM -2.54 USD
Most Recent Quarter I 2025
Quarterly Earnings Growth YOY
Profit Margin

Stock Valuation CABA

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue
Price Sales TTM
Enterprise Value EBITDA -3.44
Price Book MRQ 1.27

Technical Indicators CABA

For 52 Weeks

0.99 USD 8.44 USD
50 Day MA 1.71 USD
Shares Short Prior Month 6 465 638
200 Day MA 2.45 USD
Short Ratio 1.92
Shares Short 5 608 447
Short Percent 7.32 %